The Glasgow-based biopharmaceutical company Mironid , has successfully concluded a €39.9 million ($46 million) Series B funding round to advance its primary drug candidate for Autosomal...
En Carta Diagnostics, a DeepTech startup based in Paris, has recently secured €5 million in financing, with the first closing including €3 million in equity led...
Google recently unveiled DeepSomatic, an innovative AI tool designed to accurately detect cancer-related mutations in tumor genetic sequences. This breakthrough technology aims to revolutionize the identification...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.